Advanced Gastro Technologies, Inc. has developed a simple, innovative weight loss device that is inserted as an outpatient procedure and may be removed in minutes. This technology promises to improve the health and quality of life for people with clinically severe obesity.
AGT was founded in 2007 by Gary M. Annunziata D.O., a board certified gastroenterologist and inventor of this remarkable new weight-loss device.
Incorporated in Delaware, the company is based in Southern California. The AGT team includes physicians, regulatory and reimbursement specialists, and thought leaders
in the pharmaceutical and medical device research, development and marketing.
To date, AGT has successfully completed a significant portion of its pre-clinical trial studies and following a series of biocompatibility studies is prepared to begin a first-in-man pilot study to assess the safety, tolerability and efficacy of the novel AGT weight loss device.
AGT management plans to raise an initial round investment of $2M to file Investigational Device Exemption (IDE) with the FDA.
The Pyloric-Sphere is. Non surgical weight loss device implanted with out surgery, animal trials demonstrate promising results. We are preparing for human trials in Southern California
IP Counsel
Corporate Counsel
Mr. Shinbaum has been in involved and successful in many biotech and pharmaceutical company’s in a executive position . Ghe is serving as Cheif Executive Officer for AGT